HONGSENG

1.490

(%)

TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : NON RELATED PARTY TRANSACTIONS HONG SENG CONSOLIDATED BERHAD (FORMERLY KNOWN AS MSCM HOLDINGS BERHAD) ("HONG SENG" OR THE "COMPANY") AND ITS SUBSIDIARIES ("HONG SENG GROUP" OR THE "GROUP") - PROPOSED ACQUISITION OF 60% EQUITY INTEREST IN NEOGENIX LABORATOIRE SDN BHD

HONG SENG CONSOLIDATED BERHAD

Type Announcement
Subject TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS
Description
HONG SENG CONSOLIDATED BERHAD (FORMERLY KNOWN AS MSCM HOLDINGS BERHAD) ("HONG SENG" OR THE "COMPANY") AND ITS SUBSIDIARIES ("HONG SENG GROUP" OR THE "GROUP") - PROPOSED ACQUISITION OF 60% EQUITY INTEREST IN NEOGENIX LABORATOIRE SDN BHD

We refer to the Company's announcements made on 31 December 2020 and 6 January 2021 (“Announcements”) in relation to the Proposed Acquisition of Neogenix. Unless otherwise stated, defined terms used in this announcement shall carry the same meanings as defined in the Announcements.

 

The Company wishes to announce that the Proposed Acquisition of Neogenix has been completed today in accordance with the terms and conditions as stated in the SSA. In consequence thereof, Neogenix has become a 60% owned subsidiary of the Company on even date.

 

Furthermore, the Company would also like to provide an update on the Proposed Acquisition of Neogenix that Neogenix has recently, during the period pending Completion, further obtained a Letter of Award from Malaysia’s Ministry of Health to be one of the private laboratories to provide real-time PCR Covid-19 samples testing. This is expected to contribute positively to the overall future earnings of the Group.

 

This announcement is dated 15 January 2021.






Announcement Info

Company Name HONG SENG CONSOLIDATED BERHAD
Stock Name HONGSENG
Date Announced 15 Jan 2021
Category General Announcement for PLC
Reference Number GA1-15012021-00038